Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Viral Structure00:56

Viral Structure

75.7K
Viruses are extraordinarily diverse in shape and size, but they all have several structural features in common. All viruses have a core that contains a DNA- or RNA-based genome. The core is surrounded by a protective coat of proteins called the capsid. The capsid is composed of subunits called capsomeres. The capsid and genome-containing core are together known as the nucleocapsid.
75.7K
Vaccine Production01:23

Vaccine Production

30
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
30
Vaccines01:21

Vaccines

25
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
25

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A VLP-based immunogen that elicits selective anti-Myostatin antibodies, enhances muscle mass and strength, and reduces adiposity.

bioRxiv : the preprint server for biology·2026
Same author

A Comparative Evaluation of Adjuvants for Enhancing Antibody Responses to a Nanoparticle-Based Malaria Vaccine.

bioRxiv : the preprint server for biology·2026
Same author

Smart Nucleic Acid Chaperones: Phase-Separating Intrinsically Disordered Proteins for Accelerating DNA Hybridization Reactions.

ACS synthetic biology·2026
Same author

Immunization with VLP-based vaccines induces high IgG antibody titers in dermal interstitial fluid.

NPJ vaccines·2025
Same author

Formulation, Characterization, and In Vivo Immunogenicity of Heat-Stabilized Dissolvable Microneedles Containing a Novel VLP Vaccine.

Pharmaceutical research·2025
Same author

Nasal and Ocular Immunization with Bacteriophage Virus-like Particle Vaccines Elicits Distinct Systemic and Mucosal Antibody Profiles.

Vaccines·2025
Same journal

Nonstandard viral genomes as engines of viral evolution: ecological roles, evolutionary consequences, and insights from mathematical modeling.

Current opinion in virology·2026
Same journal

Combination adjuvants: clinical value and mechanisms of action.

Current opinion in virology·2026
Same journal

Editorial Overview: Immunopathogenesis in viral disease.

Current opinion in virology·2026
Same journal

Architecture and evolution of viral complement evasion.

Current opinion in virology·2026
Same journal

The HEV capsid through a dynamic lens: parallels and divergence from caliciviruses.

Current opinion in virology·2026
Same journal

When structural rationales fall short: revisiting the immunogenicity of herpesvirus prefusion and postfusion glycoprotein B.

Current opinion in virology·2026
See all related articles

Related Experiment Video

Updated: Mar 23, 2026

Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

22.9K

Engineering virus-like particles as vaccine platforms.

Kathryn M Frietze1, David S Peabody1, Bryce Chackerian1

  • 1Department of Molecular Genetics and Microbiology, School of Medicine, University of New Mexico, United States.

Current Opinion in Virology
|April 5, 2016
PubMed
Summary
This summary is machine-generated.

Virus-like particles (VLPs) are effective vaccine platforms. Research focuses on engineering VLPs for enhanced immunogenicity, stability, and antigen display, guiding future vaccine development.

More Related Videos

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay
05:15

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay

Published on: February 10, 2022

4.3K
A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

3.1K

Related Experiment Videos

Last Updated: Mar 23, 2026

Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

22.9K
Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay
05:15

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay

Published on: February 10, 2022

4.3K
A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

3.1K

Area of Science:

  • Biotechnology and immunology
  • Vaccine development and delivery systems

Background:

  • Virus-like particles (VLPs) are increasingly used as platforms to enhance the immunogenicity of foreign antigens.
  • Diverse VLP types exist, with ongoing research focused on optimizing their properties for vaccine applications.

Purpose of the Study:

  • To review selected VLP vaccine platforms.
  • To highlight structure-informed design strategies for VLP improvement.
  • To identify future research directions for VLP-based vaccines.

Main Methods:

  • Literature review of VLP vaccine platforms.
  • Analysis of structure-informed rational design approaches.
  • Identification of key areas for future research in VLP engineering.

Main Results:

  • Various VLP types show promise as vaccine platforms.
  • Rational design based on VLP structure can improve efficacy, stability, and antigen display.
  • Specific research areas are crucial for advancing VLP vaccine technology.

Conclusions:

  • VLP vaccine platforms offer significant potential for improved immunogenicity.
  • Structure-informed design is a key strategy for optimizing VLP vaccine performance.
  • Continued research is essential for realizing the full potential of VLP-based vaccines.